These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15975071)

  • 1. New insights into serotonin 5-HT4 receptors : a novel therapeutic target for Alzheimer's disease?
    Maillet M; Robert SJ; Lezoualc'h F
    Curr Alzheimer Res; 2004 May; 1(2):79-85. PubMed ID: 15975071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serotonin 5-HT4 receptor and the amyloid precursor protein processing.
    Lezoualc'h F; Robert SJ
    Exp Gerontol; 2003; 38(1-2):159-66. PubMed ID: 12543273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice.
    Tesseur I; Pimenova AA; Lo AC; Ciesielska M; Lichtenthaler SF; De Maeyer JH; Schuurkes JA; D'Hooge R; De Strooper B
    Neurobiol Aging; 2013 Jul; 34(7):1779-89. PubMed ID: 23474291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival.
    Cho S; Hu Y
    Exp Neurol; 2007 Jan; 203(1):274-8. PubMed ID: 16978609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin: A New Hope in Alzheimer's Disease?
    Claeysen S; Bockaert J; Giannoni P
    ACS Chem Neurosci; 2015 Jul; 6(7):940-3. PubMed ID: 26011650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral serotonin 4 receptors and amyloid-β in early Alzheimer's disease.
    Madsen K; Neumann WJ; Holst K; Marner L; Haahr MT; Lehel S; Knudsen GM; Hasselbalch SG
    J Alzheimers Dis; 2011; 26(3):457-66. PubMed ID: 21673407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT4 receptor and Alzheimer's disease: the amyloid connection.
    Lezoualc'h F
    Exp Neurol; 2007 Jun; 205(2):325-9. PubMed ID: 17346704
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.
    Nirogi R; Mohammed AR; Shinde AK; Bogaraju N; Gagginapalli SR; Ravella SR; Kota L; Bhyrapuneni G; Muddana NR; Benade V; Palacharla RC; Jayarajan P; Subramanian R; Goyal VK
    Eur J Med Chem; 2015 Oct; 103():289-301. PubMed ID: 26363507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the amyloid precursor protein ectodomain shedding by the 5-HT4 receptor and Epac.
    Robert S; Maillet M; Morel E; Launay JM; Fischmeister R; Mercken L; Lezoualc'h F
    FEBS Lett; 2005 Feb; 579(5):1136-42. PubMed ID: 15710402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease.
    Yahiaoui S; Hamidouche K; Ballandonne C; Davis A; de Oliveira Santos JS; Freret T; Boulouard M; Rochais C; Dallemagne P
    Eur J Med Chem; 2016 Oct; 121():283-293. PubMed ID: 27266998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT
    Nirogi R; Mohammed AR; Shinde AK; Gagginapally SR; Kancharla DM; Ravella SR; Bogaraju N; Middekadi VR; Subramanian R; Palacharla RC; Benade V; Muddana N; Abraham R; Medapati RB; Thentu JB; Mekala VR; Petlu S; Lingavarapu BB; Yarra S; Kagita N; Goyal VK; Pandey SK; Jasti V
    J Med Chem; 2021 Aug; 64(15):10641-10665. PubMed ID: 34251799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years.
    Modica MN; Pittalà V; Romeo G; Salerno L; Siracusa MA
    Curr Med Chem; 2010; 17(4):334-62. PubMed ID: 20015043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment.
    Shen F; Smith JA; Chang R; Bourdet DL; Tsuruda PR; Obedencio GP; Beattie DT
    Neuropharmacology; 2011; 61(1-2):69-79. PubMed ID: 21392515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel multi target-directed ligands targeting 5-HT
    Lanthier C; Payan H; Liparulo I; Hatat B; Lecoutey C; Since M; Davis A; Bergamini C; Claeysen S; Dallemagne P; Bolognesi ML; Rochais C
    Eur J Med Chem; 2019 Nov; 182():111596. PubMed ID: 31419776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT₄ receptor stimulation leads to soluble AβPPα production through MMP-9 upregulation.
    Hashimoto G; Sakurai M; Teich AF; Saeed F; Aziz F; Arancio O
    J Alzheimers Dis; 2012; 32(2):437-45. PubMed ID: 22810092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From acetylcholine to amyloid: neurotransmitters and the pathology of Alzheimer's disease.
    Nitsch RM
    Neurodegeneration; 1996 Dec; 5(4):477-82. PubMed ID: 9117566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Molecular Basis of 5-HT
    Castro-Alvarez A; Chávez-Ángel E; Nelson R
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of 5-HT4R ligands: state of art and clinical applications.
    Bureau R; Boulouard M; Dauphin F; Lezoualc'h F; Rault S
    Curr Top Med Chem; 2010; 10(5):527-53. PubMed ID: 20166943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease.
    Russo O; Cachard-Chastel M; Rivière C; Giner M; Soulier JL; Berthouze M; Richard T; Monti JP; Sicsic S; Lezoualc'h F; Berque-Bestel I
    J Med Chem; 2009 Apr; 52(8):2214-25. PubMed ID: 19334715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.
    Ramirez MJ; Lai MK; Tordera RM; Francis PT
    Drugs; 2014 May; 74(7):729-36. PubMed ID: 24802806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.